CareFusion Provides Further Information on Recall

CareFusion has released more information about its July 13 recall of 17,000 Alaris PC infusion units. The units, designed to deliver controlled amounts of medications and fluids through intravenous, intra-arterial, and epidural routes, were recalled after the company learned of a wireless communication error that can cause the device screen to freeze, delaying treatment and possibly resulting in death. The FDA has labeled the recall Class I.